Braun Stacey Associates’s Kyndryl KD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-225,644
Closed -$6.78M 115
2025
Q3
$6.78M Sell
225,644
-291,615
-56% -$10M 0.22% 86
2025
Q2
$21.7M Buy
517,259
+289,724
+127% +$10.5M 0.79% 55
2025
Q1
$7.14M Buy
+227,535
New +$8.53M 0.29% 82

Other funds holding KD

Braun Stacey Associates's KD Position: Q4 2025 in Review

Braun Stacey Associates sold out of Kyndryl (KD) in Q4 2025, closing a stake of 225,644 shares — an estimated $6.78M sold.

Braun Stacey Associates first reported a position in KD in Q1 2025 and held it in 3 quarters. The position peaked at $21.7M in Q2 2025. 704 funds tracked by Wall St. Rank hold KD as of Q4 2025.

  • Braun Stacey Associates reported no remaining Kyndryl position as of Q4 2025 after selling out during the quarter.
  • Braun Stacey Associates sold 225,644 Kyndryl shares in Q4 2025, an estimated $6.78M.
  • Braun Stacey Associates first reported a position in Kyndryl in Q1 2025 and held it in 3 quarters.
  • Braun Stacey Associates's Kyndryl position peaked at $21.7M in Q2 2025.
  • 704 funds tracked by Wall St. Rank held Kyndryl as of Q4 2025.

Based on Braun Stacey Associates's 13F filing for Q4 2025, filed 20 Jan 2026.